CPT code 54530 denotes a radical inguinal orchiectomy: the complete excision of one or both testes via an inguinal approach to treat a testicular tumor. This procedure is a definitive diagnostic and therapeutic surgical oncology intervention for testicular masses and has implications for cancer staging, pathology, and subsequent oncologic management.

Key national payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for when CPT code 54530 is used, typical sites of service, common billing modifiers (listed separately), and how the code fits into surgical oncology service lines. The publication also outlines benchmarking and reimbursement context, payer coverage considerations, and common documentation elements that support medical necessity.

This overview is intended for clinicians, coding professionals, and policy analysts who need a clear, national-level summary of CPT code 54530, its clinical purpose, and the operational settings where the procedure is performed. Data not available in the input are noted where applicable elsewhere in the full publication.